Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly
Clinical trial NCT01412424 · COMPLETED
Trial details
- NCT number
- NCT01412424
- Sponsor
- Chiasma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-05-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.